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Annika van Hummel, 1, 2 Claire H. Stevens, 1 Stefania Ippati, 1 Lisa S. Suh, 1, 3 Alexander Macmillan, 4 Greg Sutherland, 3 Jillian J. Kril, 3 Ana P. G. Silva, 5 Joel P. Mackay, 5 Anne Poljak, 6 Fabien Delerue, 1, 7 Yazi D. Ke, 2 Lars M. Ittner 1,7,8 * Amyloid-b (Ab) toxicity in Alzheimer's disease (AD) is considered to be mediated by phosphorylated tau protein. In contrast, we found that, at least in early disease, site-specific phosphorylation of tau inhibited Ab toxicity. This specific tau phosphorylation was mediated by the neuronal p38 mitogen-activated protein kinase p38g and interfered with postsynaptic excitotoxic signaling complexes engaged by Ab. Accordingly, depletion of p38g exacerbated neuronal circuit aberrations, cognitive deficits, and premature lethality in a mouse model of AD, whereas increasing the activity of p38g abolished these deficits. Furthermore, mimicking site-specific tau phosphorylation alleviated Ab-induced neuronal death and offered protection from excitotoxicity. Our work provides insights into postsynaptic processes in AD pathogenesis and challenges a purely pathogenic role of tau phosphorylation in neuronal toxicity.
A lzheimer's disease (AD), the most prevalent form of dementia, is neuropathologically characterized by extracellular amyloid-b (Ab) plaques and intracellular tau-containing neurofibrillary tangles (1, 2) . Growing evidence suggests that Ab and tau together orchestrate neuronal dysfunction in AD (3), although their molecular connections remain poorly understood. Aberrant tau phosphorylation is the first step in a cascade leading to its deposition and to cognitive dysfunction (4, 5) . Ab is thought to trigger toxic events, including tau phosphorylation (6) . Accordingly, the depletion of tau prevents Ab toxicity in AD models (7) (8) (9) . Ab-induced neuronal network and synaptic dysfunction is associated with aberrant glutamatergic synaptic transmission (10) . N-methyl-D-aspartate (NMDA)-type glutamatergic receptors (NRs) drive glutamateinduced neuronal excitotoxicity (11) and mediate Ab toxicity by downstream responses that promote neuronal dysfunction (12) .
Multiple factors, including p38 kinases, contribute to NR-mediated toxicity (12) . Although inhibition of p38a and p38b improves Ab-induced long-term potentiation deficits (13, 14) , it increases hyperexcitability in Ab precursor protein (APP) transgenic mice (15) . However, the specificity of p38 inhibitors remains debatable (16, 17) . Other p38 kinases, p38g and p38d, have not been studied in AD. To understand the roles of p38 kinases in AD, we induced excitotoxic seizures with pentylenetetrazole (PTZ), an approach widely used for studying excitotoxicity in AD mouse models (8, 9) . We used mice with individual deletion of p38a, p38b, p38g, or p38d ( fig. S1 ). Surprisingly, only p38g depletion (p38g sciencemag.org SCIENCE knockout, changed PTZ-induced seizures (Fig.  1A and fig. S2 ). Pan-p38 inhibition in wild-type (WT) mice augmented seizures, similar to the effects of p38g depletion ( fig. S3 ). Consistent with a postsynaptic role, only p38g localized to dendritic spines and postsynaptic densities (PSDs) of neurons and was enriched in PSD preparations (Fig. 1B and fig. S4 ). Hence, of all p38 kinases, only p38g localized to postsynapses and limited excitotoxicity. .p38g −/− mice (n = 10 to 12). For all panels: ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05; ns, not significant. Error bars indicate SEM. and Ab pathology (9, 15, 18 fig. S6 ), but p38g deletion aggravated premature mortality and memory deficits of APP23 mice (Fig. 1, C to F,  and fig. S7 ). p38g −/− mice showed no deficits and had normal motor function ( fig. S8 ). Electroencephalography showed enhanced spontaneous epileptiform activity and interictal hypersynchronous discharges in APP23.p38g −/− compared with APP23.p38g +/+ mice (Fig. 1, G and H, and fig. S9 ). Hippocampal theta and gamma oscillations and cross-frequency coupling (CFC) through thetaphase modulation of gamma power are measures of network activity related to memory, including in humans (19) (20) (21) (22) . These measures are compromised in APP transgenic mice (15) . Compromised spectral power and CFC of APP23.p38g +/+ mice were significantly more affected in APP23.p38g −/− recordings (Fig. 1, I and J, and fig. S9 ). Recordings of p38g −/− and p38g +/+ mice were indistinguishable. In summary, p38g depletion exacerbated excitotoxicity, neuronal circuit synchronicity, mortality, and memory deficits in APP23 mice, without changes in Ab pathology. In addition, p38g levels were reduced in aged APP23 and APP NL-G-F mice and humans with AD ( fig. S10 ), further suggesting that the loss of p38g-mediated neuroprotection may contribute to AD pathogenesis.
To determine whether the Ab toxicity-limiting effects of p38g were tau-dependent, we crossed APP23.p38g −/− with tau −/− mice. The exacerbating effects of p38g loss on reduced survival, memory deficits, and neuronal network dysfunction of APP23 mice were virtually abolished in APP23.p38g
.tau −/− mice (Fig. 2 , A to C, and fig. S11 ). These data also showed that, compared with APP23 mice, APP23.p38g −/− animals had aggravated memory deficits that persisted with aging. In contrast, increasing tau levels in p38g −/− mice [brought about by crossing with nonmutant tau-expressing Alz17 mice (23)] significantly enhanced PTZ-induced seizures in Alz17.p38g −/− mice (Fig. 2, D to F) . Conversely, when compared to tau
−/− animals showed similar protection from PTZ-induced seizures (Fig. 2, G to I ). Taken together, the effects of p38g on excitotoxicity and Ab toxicity were tau-dependent. We have previously shown that postsynaptic PSD-95/tau/Fyn complexes mediate Ab-induced excitotoxicity (9) . PSD-95/tau/Fyn interaction was enhanced in Alz17.p38g
−/− animals versus Alz17.
p38g +/+ mice ( Fig. 3A and fig. S12 ). Conversely, no PSD-95/tau/Fyn complexes were isolated from tau −/− and tau S12 ). Increasing p38g levels compromised PSD-95/tau/ Fyn interaction in cells, and expression of a constitutively active p38g variant (p38g CA ) completely abolished this interaction (Fig. 3B and  fig. S13 ). Pan-p38 inhibition stopped p38g/p38g CA -induced disruption of PSD-95/tau/Fyn complexes (Fig. 3B) . PSD-95 copurified more tau and Fyn from p38g −/− versus p38g +/+ brains, and even more from APP23.p38g
−/− compared with APP23.
p38g
+/+ and p38g −/− brains (Fig. 3C) . Conversely, PSD-95/tau/Fyn interaction was reduced in transgenic mice with neuronal expression of p38g CA ( Fig. 3D and fig. S14 ). PTZ transiently increased PSD-95/tau/Fyn complex formation in p38g Although p38g hyperphosphorylates tau during long-term in vitro kinase assays (25) , the temporal profile of p38g-induced tau phosphorylation in acute signaling remains unknown. Short-term in vitro kinase reactions using phosphorylation site-specific tau antibodies revealed phosphorylation at Ser 199 (S199), Thr 205 (T205), S396, and S404 ( fig. S17 ). Mass spectrometric analysis confirmed these and 14 additional, though low-abundant, sites (figs. S17C and S18 and table S4). Coexpression of p38g or p38g CA and tau in cells revealed tau phosphorylation (p) at T205, less at S199, and hardly any at S396 or S404 (Fig. 4A) . Similarly, T205 (and, less so, S199 and S396) were phosphorylated in p38g CA transgenic mice (fig. S19 ). pT205 increased after PTZ in p38g +/+ animals but was virtually abolished in p38g −/− mice, whereas pS199, pS396, and pS404
were induced in both p38g +/+ and p38g −/− mice ( fig. S19 ). Similarly, pT205 was markedly reduced in APP23.p38g −/− animals compared with APP23. p38g +/+ mice (Fig. 4B) . In primary neurons, pT205 (but not p199) was markedly reduced by pan-p38 inhibition ( fig. S20 ). Taken together, these findings indicate that pT205 was a primary p38g site in tau.
Next, we showed that a phosphorylationmimicking Thr 205 →Glu 205 (T205E) tau variant coprecipitated significantly less with PSD-95 as compared with nonmutant and T205A (A, Ala) tau (Fig. 4C and fig. S21 ). In contrast, phosphorylationmimicking mutants of all other identified sites had no effect on PSD- The disruption of NR/PSD-95/tau/Fyn complexes prevents excitotoxicity and Ab toxicity (9) . Hence, phosphorylation of tau at T205 should similarly mitigate neurotoxicity. Ab caused cell death in WT and T205A neurons but significantly less in T205E tau-expressing neurons ( fig. S23) . Similarly, neurons expressing p38g and, more so, p38g
CA were significantly more resistant to Ab-induced cell death than controls ( fig. S24 ). PTZ-induced seizures are reduced in tau −/− mice (8, 9) . Adeno-associated virus (AAV)-mediated expression of WT and T205A neurons, but not T205E tau or green fluorescent protein (GFP), in the forebrains of tau −/− mice enhanced PTZ-induced seizures (Fig. 4D and fig. S25 ). In contrast, expression of p38g CA in WT mice using AAV or in Thy1. 2-p38g CA transgenic mice decreased PTZ-induced seizures ( fig. S25 ). AAVmediated p38g
CA expression in APP23 mice rescued memory deficits and network aberrations; the same was true for crossing APP23 with Thy1.2-p38g CA mice (Fig. 4 , E and F, and figs. S26 and S27). In summary, the levels of active p38g kinase and tau phosphorylation at T205 determined susceptibility to excitotoxicity and Ab toxicity.
Here we have shown that T205 phosphorylation of tau is part of an Ab toxicity-inhibiting response. This is contrary to the current view that tau phosphorylation downstream of Ab toxicity is a pathological response (3). However, this finding is in line with the idea that tau is involved in normal physiologic NR signaling events in neurons (12) . Finally, we found that taudependent Ab toxicity was modulated by sitespecific tau phosphorylation, which inhibited postsynaptic PSD-95/tau/Fyn complexes, revealing an Ab toxicity-limiting role of p38g in AD that is distinct and opposite to the effects of p38a and p38b (11, 13, 14) .
